This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1994 Jan 8;308(6921):72-4.

doi: 10.1136/bmj.308.6921.72.

Who benefits from medical interventions?

G D Smith, M Egger

PMID: 8298415
PMCID: PMC2539180
DOI: 10.1136/bmj.308.6921.72

Editorial

Who benefits from medical interventions?

G D Smith et al. BMJ. 1994.

. 1994 Jan 8;308(6921):72-4.

doi: 10.1136/bmj.308.6921.72.

Authors

G D Smith, M Egger

PMID: 8298415
PMCID: PMC2539180
DOI: 10.1136/bmj.308.6921.72

No abstract available

PubMed Disclaimer

Comment on

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
[No authors listed] [No authors listed] BMJ. 1994 Jan 8;308(6921):81-106. BMJ. 1994. PMID: 8298418 Free PMC article.

References

1. Ann Intern Med. 1993 Aug 15;119(4):329-35 - PubMed
1. BMJ. 1993 Jul 10;307(6896):107-10 - PubMed
1. Lancet. 1993 Nov 20;342(8882):1291-2 - PubMed
1. BMJ. 1993 Nov 20;307(6915):1322-5 - PubMed
1. N Engl J Med. 1982 Feb 4;306(5):297-8 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information